<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">35529336</PMID><DateRevised><Year>2022</Year><Month>05</Month><Day>10</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2296-2360</ISSN><JournalIssue CitedMedium="Print"><Volume>10</Volume><PubDate><Year>2022</Year></PubDate></JournalIssue><Title>Frontiers in pediatrics</Title><ISOAbbreviation>Front Pediatr</ISOAbbreviation></Journal><ArticleTitle>Post-COVID Condition in Adults and Children Living in the Same Household in Italy: A Prospective Cohort Study Using the ISARIC Global Follow-Up Protocol.</ArticleTitle><Pagination><StartPage>834875</StartPage><MedlinePgn>834875</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">834875</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fped.2022.834875</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">Emerging evidence shows that both adults and children may develop post-acute sequelae of SARS-CoV-2 infection (PASC). The aim of this study is to characterise and compare long-term post-SARS-CoV-2 infection outcomes in adults and children in a defined region in Italy.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">A prospective cohort study including children (&#x2264;18 years old) with PCR-confirmed SARS-CoV-2 infection and their household members. Participants were assessed via telephone and face-to-face visits up to 12 months post-SARS-CoV-2 diagnosis of household index case, using the ISARIC COVID-19 follow-up survey.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">Of 507 participants from 201 households, 56.4% (286/507) were children, 43.6% (221/507) adults. SARS-CoV-2 positivity was 87% (249/286) in children, and 78% (172/221) in adults. The mean age of PCR positive children was 10.4 (SD = 4.5) and of PCR positive adults was 44.5 years (SD = 9.5), similar to the PCR negative control groups [children 10.5 years (SD = 3.24), adults 42.3 years (SD = 9.06)]. Median follow-up post-SARS-CoV-2 diagnosis was 77 days (IQR 47-169). A significantly higher proportion of adults compared to children reported at least one persistent symptom (67%, 68/101 vs. 32%, 57/179, <i>p</i> &lt; 0.001) at the first follow up. Adults had more frequently coexistence of several symptom categories at both follow-up time-points. Female gender was identified as a risk factor for PASC in adults (<i>p</i> 0.02 at 1-3 months and <i>p</i> 0.01 at 6-9 months follow up), but not in children. We found no significant correlation between adults and children symptoms. In the paediatric group, there was a significant difference in persisting symptoms between those with confirmed SARS-CoV-2 infection compared to controls at 1-3 months follow up, but not at 6-9 months. Conversely, positive adults had a higher frequency of persisting symptoms at both follow-up assessments.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">Our data highlights that children can experience persistent multisystemic symptoms months after diagnosis of mild acute SARS-CoV-2 infection, although less frequently and less severely than co-habitant adults. There was no correlation between symptoms experienced by adults and children living in the same household. Our data highlights an urgent need for studies to characterise PASC in whole populations and the wider impact on families.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 Buonsenso, Munblit, Pazukhina, Ricchiuto, Sinatti, Zona, De Matteis, D&#x2019;Ilario, Gentili, Lanni, Rongai, del Balzo, Fonte, Valente, Zampino, De Rose, Sigfrid, Valentini and FIMP-Roma.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Buonsenso</LastName><ForeName>Danilo</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Woman and Child Health and Public Health, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Global Health Research Institute, Istituto di Igiene, Universit&#xe0; Cattolica del Sacro Cuore, Rome, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Sezione di Microbiologia, Dipartimento di Scienze Biotecnologiche di Base, Cliniche Intensivologiche e Perioperatorie, Universit&#xe0; Cattolica del Sacro Cuore, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Munblit</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Paediatrics and Paediatric Infectious Diseases, Institute of Child's Health, I.M. Sechenov First Moscow State Medical University, Sechenov University, Moscow, Russia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Inflammation, Repair and Development Section, Faculty of Medicine, National Heart and Lung Institute, Imperial College London, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pazukhina</LastName><ForeName>Ekaterina</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Laboratory of Health Economics, Institute of Applied Economic Studies, Russian Presidential Academy of National Economy and Public Administration, Moscow, Russia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Advanced Financial Planning, Macroeconomic Analysis and Financial Statistics, Financial Research Institute, Ministry of Finance of the Russian Federation, Moscow, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ricchiuto</LastName><ForeName>Antonia</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Woman and Child Health and Public Health, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sinatti</LastName><ForeName>Dario</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Woman and Child Health and Public Health, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zona</LastName><ForeName>Margherita</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Woman and Child Health and Public Health, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>De Matteis</LastName><ForeName>Alessia</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Woman and Child Health and Public Health, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>D'Ilario</LastName><ForeName>Federico</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Woman and Child Health and Public Health, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gentili</LastName><ForeName>Carolina</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Woman and Child Health and Public Health, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lanni</LastName><ForeName>Roberta</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Pediatra di Libera Scelta, Federazione Italiana Medici Pediatri, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rongai</LastName><ForeName>Teresa</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Pediatra di Libera Scelta, Federazione Italiana Medici Pediatri, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Del Balzo</LastName><ForeName>Patrizia</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Pediatra di Libera Scelta, Federazione Italiana Medici Pediatri, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fonte</LastName><ForeName>Maria Teresa</ForeName><Initials>MT</Initials><AffiliationInfo><Affiliation>Pediatra di Libera Scelta, Federazione Italiana Medici Pediatri, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Valente</LastName><ForeName>Michele</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Pediatra di Libera Scelta, Federazione Italiana Medici Pediatri, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zampino</LastName><ForeName>Giuseppe</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Woman and Child Health and Public Health, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>De Rose</LastName><ForeName>Cristina</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Woman and Child Health and Public Health, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sigfrid</LastName><ForeName>Louise</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>International Severe Acute Respiratory and Emerging Infection Consortium Global Support Centre, Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Valentini</LastName><ForeName>Piero</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Woman and Child Health and Public Health, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Global Health Research Institute, Istituto di Igiene, Universit&#xe0; Cattolica del Sacro Cuore, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>FIMP-Roma</CollectiveName></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>04</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Pediatr</MedlineTA><NlmUniqueID>101615492</NlmUniqueID><ISSNLinking>2296-2360</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">adults</Keyword><Keyword MajorTopicYN="N">children</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">post-COVID &#x201c;long-haulers&#x201d;</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement><InvestigatorList><Investigator ValidYN="Y"><LastName>Sani</LastName><ForeName>Ilaria</ForeName><Initials>I</Initials></Investigator><Investigator ValidYN="Y"><LastName>La Cava</LastName><ForeName>Giovanna</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Castronuovo</LastName><ForeName>Serenella</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Capodici</LastName><ForeName>Isabella</ForeName><Initials>I</Initials></Investigator><Investigator ValidYN="Y"><LastName>Zirletta</LastName><ForeName>Ermenia</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Costabile</LastName><ForeName>Loredana</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Martino</LastName><ForeName>Di</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Arnaboldi</LastName><ForeName>Lorenza</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Carbone</LastName><ForeName>Maria Concetta</ForeName><Initials>MC</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sebastianelli</LastName><ForeName>Rosella</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ciuffo</LastName><ForeName>Cristina</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Marano</LastName><ForeName>Donatella</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Grassi</LastName><ForeName>Cinzia</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bella</LastName><ForeName>Immacolata La</ForeName><Initials>I</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sozio</LastName><ForeName>Luciano</ForeName><Initials>L</Initials></Investigator></InvestigatorList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>12</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>3</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>5</Month><Day>9</Day><Hour>4</Hour><Minute>8</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>5</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>5</Month><Day>10</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>4</Month><Day>21</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35529336</ArticleId><ArticleId IdType="pmc">PMC9070551</ArticleId><ArticleId IdType="doi">10.3389/fped.2022.834875</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>RECOVERY Collaborative Group, Horby P, Lim WS, Emberson JR, Mafham M, Bell JL, et al. Dexamethasone in hospitalized patients with Covid-19. N Engl J Med. (2021) 384:693&#x2013;704. 10.1056/NEJMoa2021436</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2021436</ArticleId><ArticleId IdType="pmc">PMC7383595</ArticleId><ArticleId IdType="pubmed">32678530</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu B, Guo H, Zhou P, Shi ZL. Characteristics of SARS-CoV-2 and COVID-19. Nat Rev Microbiol. (2021) 19:141&#x2013;54. 10.1038/s41579-020-00459-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-020-00459-7</ArticleId><ArticleId IdType="pmc">PMC7537588</ArticleId><ArticleId IdType="pubmed">33024307</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A, Sehgal K, Gupta A, Madhavan MV, McGroder C, Stevens JS, et al. Post-acute COVID-19 syndrome. Nat Med. (2021) 27:601&#x2013;15. 10.1038/s41591-021-01283-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01283-z</ArticleId><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalkeri R, Goebel S, Sharma GD. SARS-CoV-2 shedding from asymptomatic patients: contribution of potential extrapulmonary tissue reservoirs. Am J Trop Med Hyg. (2020) 103:18&#x2013;21. 10.4269/ajtmh.20-0279</Citation><ArticleIdList><ArticleId IdType="doi">10.4269/ajtmh.20-0279</ArticleId><ArticleId IdType="pmc">PMC7356473</ArticleId><ArticleId IdType="pubmed">32406369</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoang VT, Dao TL, Gautret P. Recurrence of positive SARS-CoV-2 in patients recovered from COVID-19. J Med Virol. (2020) 92:2366&#x2013;7. 10.1002/jmv.26056</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26056</ArticleId><ArticleId IdType="pmc">PMC7280660</ArticleId><ArticleId IdType="pubmed">32449789</ArticleId></ArticleIdList></Reference><Reference><Citation>Proal AD, VanElzakker MB. Long COVID or post-acute sequelae of COVID-19 (PASC): an overview of biological factors that may contribute to persistent symptoms. Front Microbiol. (2021) 12:698169. 10.3389/fmicb.2021.698169</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2021.698169</ArticleId><ArticleId IdType="pmc">PMC8260991</ArticleId><ArticleId IdType="pubmed">34248921</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO.
WHO Post Covid Condition. (2021). Available online at: https://www.who.int/publications/i/item/WHO-2019-nCoV-Post_COVID-19_condition-Clinical_case_definition-2021.1
(accessed October 6, 2021).</Citation></Reference><Reference><Citation>Gaythorpe KAM, Bhatia S, Mangal T, Unwin HJT, Imai N, Cuomo-Dannenburg G, et al. Children&#x2019;s role in the COVID-19 pandemic: a systematic review of early surveillance data on susceptibility, severity, and transmissibility. Sci Rep. (2021) 11:13903. 10.1038/s41598-021-92500-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-92500-9</ArticleId><ArticleId IdType="pmc">PMC8260804</ArticleId><ArticleId IdType="pubmed">34230530</ArticleId></ArticleIdList></Reference><Reference><Citation>Osmanov IM, Spiridonova E, Bobkova P, Gamirova A, Shikhaleva A, Andreeva M, et al. Risk factors for post-COVID-19 condition in previously hospitalised children using the ISARIC Global follow-up protocol: a prospective cohort study. Eur Respir J. (2021) 59:2101341. 10.1183/13993003.01341-2021</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.01341-2021</ArticleId><ArticleId IdType="pmc">PMC8576804</ArticleId><ArticleId IdType="pubmed">34210789</ArticleId></ArticleIdList></Reference><Reference><Citation>Buonsenso D, Munblit D, De Rose C, Sinatti D, Ricchiuto A, Carfi A, et al. Preliminary evidence on long COVID in children. Acta Paediatr. (2021) 110:2208&#x2013;11. 10.1111/apa.15870</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/apa.15870</ArticleId><ArticleId IdType="pmc">PMC8251440</ArticleId><ArticleId IdType="pubmed">33835507</ArticleId></ArticleIdList></Reference><Reference><Citation>Buonsenso D, Di Giuda D, Sigfrid L, Pizzuto DA, Di Sante G, De Rose C, et al. Evidence of lung perfusion defects and ongoing inflammation in an adolescent with post-acute sequelae of SARS-CoV-2 infection. Lancet Child Adolesc Health. (2021) 5:677&#x2013;80. 10.1016/S2352-4642(21)00196-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2352-4642(21)00196-6</ArticleId><ArticleId IdType="pmc">PMC8324416</ArticleId><ArticleId IdType="pubmed">34339624</ArticleId></ArticleIdList></Reference><Reference><Citation>Michelen M, Manoharan L, Elkheir N, Cheng V, Dagens A, Hastie C, et al. Characterising long COVID: a living systematic review. BMJ Glob Health. (2021) 6:e005427. 10.1136/bmjgh-2021-005427</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjgh-2021-005427</ArticleId><ArticleId IdType="pmc">PMC8478580</ArticleId><ArticleId IdType="pubmed">34580069</ArticleId></ArticleIdList></Reference><Reference><Citation>Molteni E, Sudre CH, Canas LS, Bhopal SS, Hughes RC, Antonelli M, et al. Illness duration and symptom profile in symptomatic UK school-aged children tested for SARS-CoV-2. Lancet Child Adolesc Health. (2021) 5:708&#x2013;18. 10.1016/S2352-4642(21)00198-X</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2352-4642(21)00198-X</ArticleId><ArticleId IdType="pmc">PMC8443448</ArticleId><ArticleId IdType="pubmed">34358472</ArticleId></ArticleIdList></Reference><Reference><Citation>Radtke T, Ulyte A, Puhan MA, Kriemler S. Long-term symptoms after SARS-CoV-2 infection in children and adolescents. JAMA. (2021) 326:869&#x2013;71. 10.1001/jama.2021.11880</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2021.11880</ArticleId><ArticleId IdType="pmc">PMC8283661</ArticleId><ArticleId IdType="pubmed">34264266</ArticleId></ArticleIdList></Reference><Reference><Citation>Munblit D, Sigfrid L, Warner JO. Setting priorities to address research gaps in long-term COVID-19 outcomes in children. JAMA Pediatr. (2021) 175:1095&#x2013;6. 10.1001/jamapediatrics.2021.2281</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamapediatrics.2021.2281</ArticleId><ArticleId IdType="pubmed">34338711</ArticleId></ArticleIdList></Reference><Reference><Citation>ISARIC.
ISARIC. (2021). Available online at: https://isaric.org/document/covid-19-long-term-follow-up-study/</Citation></Reference><Reference><Citation>Ministry of Health.
Diagnostic Tests and Contact Tracing. (2021). Available online at: https://www.salute.gov.it/portale/nuovocoronavirus/dettaglioNotizieNuovoCoronavirus.jsp?lingua=italiano&amp;id=5117
(accessed October 15, 2021).</Citation></Reference><Reference><Citation>ISARIC.
ISARIC Global Survey. (2021). Available online at: https://isaric.org/wp-content/uploads/2020/12/Tier-1-Initial-Follow_up_survey.pdf
(accessed October 2021).</Citation></Reference><Reference><Citation>Sigfrid L, Drake TM, Pauley E, Jesudason EC, Olliaro P, Lim WS, et al. Long Covid in adults discharged from UK hospitals after Covid-19: a prospective, multicentre cohort study using the ISARIC WHO clinical characterisation protocol. Lancet Reg Health Eur. (2021) 8:100186. 10.1016/j.lanepe.2021.100186</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lanepe.2021.100186</ArticleId><ArticleId IdType="pmc">PMC8343377</ArticleId><ArticleId IdType="pubmed">34386785</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenhalgh T, Knight M, A&#x2019;Court C, Buxton M, Husain L. Management of post-acute covid-19 in primary care. BMJ. (2020) 370:m3026. 10.1136/bmj.m3026</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m3026</ArticleId><ArticleId IdType="pubmed">32784198</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams K, Thomson D, Seto I, Contopoulos-Ioannidis DG, Ioannidis JP, Curtis S, et al. Standard 6: age groups for pediatric trials. Pediatrics. (2012) 129:S153&#x2013;60. 10.1542/peds.2012-0055I</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.2012-0055I</ArticleId><ArticleId IdType="pubmed">22661762</ArticleId></ArticleIdList></Reference><Reference><Citation>Crawley SA, Caporino NE, Birmaher B, Ginsburg G, Piacentini J, Albano AM, et al. Somatic complaints in anxious youth. Child Psychiatry Hum Dev. (2014) 45:398&#x2013;407. 10.1007/s10578-013-0410-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10578-013-0410-x</ArticleId><ArticleId IdType="pmc">PMC3989467</ArticleId><ArticleId IdType="pubmed">24129543</ArticleId></ArticleIdList></Reference><Reference><Citation>Crook H, Raza S, Nowell J, Young M, Edison P. Long covid-mechanisms, risk factors, and management. BMJ. (2021) 374:n1648. 10.1136/bmj.n1648</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n1648</ArticleId><ArticleId IdType="pubmed">34312178</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, Assaf GS, McCorkell L, Wei H, Low RJ, Re&#x2019;em Y, et al. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine. (2021) 38:101019. 10.1016/j.eclinm.2021.101019</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.101019</ArticleId><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Costagliola G, Spada E, Consolini R. Age-related differences in the immune response could contribute to determine the spectrum of severity of COVID-19. Immun Inflamm Dis. (2021) 9:331&#x2013;9. 10.1002/iid3.404</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/iid3.404</ArticleId><ArticleId IdType="pmc">PMC8014746</ArticleId><ArticleId IdType="pubmed">33566457</ArticleId></ArticleIdList></Reference><Reference><Citation>Brodin P. Immune determinants of COVID-19 disease presentation and severity. Nat Med. (2021) 27:28&#x2013;33. 10.1038/s41591-020-01202-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-020-01202-8</ArticleId><ArticleId IdType="pubmed">33442016</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y, Klein SL, Garibaldi BT, Li H, Wu C, Osevala NM, et al. Aging in COVID-19: vulnerability, immunity and intervention. Ageing Res Rev. (2021) 65:101205. 10.1016/j.arr.2020.101205</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arr.2020.101205</ArticleId><ArticleId IdType="pmc">PMC7604159</ArticleId><ArticleId IdType="pubmed">33137510</ArticleId></ArticleIdList></Reference><Reference><Citation>Cotugno N, Ruggiero A, Pascucci GR, Bonfante F, Petrara MR, Pighi C, et al. Virological and immunological features of SARS-COV-2 infected children with distinct symptomatology. Pediatr Allergy Immunol. (2021) 32:1833&#x2013;42. 10.1111/pai.13585</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/pai.13585</ArticleId><ArticleId IdType="pmc">PMC8420243</ArticleId><ArticleId IdType="pubmed">34174102</ArticleId></ArticleIdList></Reference><Reference><Citation>Cotugno N, Ruggiero A, Bonfante F, Petrara MR, Zicari S, Pascucci GR, et al. Virological and immunological features of SARS-CoV-2-infected children who develop neutralizing antibodies. Cell Rep. (2021) 34:108852. 10.1016/j.celrep.2021.108852</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2021.108852</ArticleId><ArticleId IdType="pmc">PMC7962998</ArticleId><ArticleId IdType="pubmed">33730580</ArticleId></ArticleIdList></Reference><Reference><Citation>Radzikowska U, Ding M, Tan G, Zhakparov D, Peng Y, Wawrzyniak P, et al. Distribution of ACE2, CD147, CD26, and other SARS-CoV-2 associated molecules in tissues and immune cells in health and in asthma, COPD, obesity, hypertension, and COVID-19 risk factors. Allergy. (2020) 75:2829&#x2013;45. 10.1111/all.14429</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/all.14429</ArticleId><ArticleId IdType="pmc">PMC7300910</ArticleId><ArticleId IdType="pubmed">32496587</ArticleId></ArticleIdList></Reference><Reference><Citation>Hillis SD, Unwin HJT, Chen Y, Cluver L, Sherr L, Goldman PS, et al. Global minimum estimates of children affected by COVID-19-associated orphanhood and deaths of caregivers: a modelling study. Lancet. (2021) 398:391&#x2013;402. 10.1016/S0140-6736(21)01253-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(21)01253-8</ArticleId><ArticleId IdType="pmc">PMC8293949</ArticleId><ArticleId IdType="pubmed">34298000</ArticleId></ArticleIdList></Reference><Reference><Citation>The Guardian.
More Than 2m Adults in England Have Had Long Covid for Over 12 Weeks &#x2013; Study. (2021). Available online at: https://www.theguardian.com/society/2021/jun/24/more-than-2m-adults-in-england-have-had-long-covid-for-over-12-weeks-study
(accessed October 2021).</Citation></Reference><Reference><Citation>Long Covid Support. Long Covid Support. (2021). Available online at: https://www.longcovid.org
(accessed October 2021).</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>